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Altered Coronary Vasodilator Reserve
	
is i
Myocardlium, Subtended by Normal Arteries in Patients With
Coronary Artery Disease
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Oljeclives. The aim of this study was to investigate coronary
Qatar reserve and metabolism in myocardlum subtended by
phicatly normal arteries remote from ischemia .
Rockgroand. After infarction, structural and functional
clumM occur in remote myocardium often subtended by normal
arteries . Whether changes occur in regions remote from ischelnic
but noninfarcted myocardlum is unknown .
Me . Coronary vasodilator reserve was measured with
positron emission to phy in 12 patients with single-vessel
using intravenous dipyridamole (0.56 mg/kg for 4 min). In
anouewe 10 patients, simultaneous arterial/great cardiac vein
catheterization was performed during atrial pacing to measure
myocardial metabolism in regions subtended by diseased or
no arteries.
Results. Basal myocardial blood flow in stenosis .related regions
was comparable to that in remote regions but was lower after
dlpyri ole administration (1 .73 : 0.91 vs . 2.89 ± 0 .93 mi/min
per g, p < 0.01), giving coronary vasodilator e rvg; values of
There is increasing evidence that after myocardial infarction,
structural and functional changes occur in the remote non-
infarcted regions of the left ventricle, which :ire often
subtended by angiographically normal vessels, in a process
termed ventricular remodeling . Noninfarcted myocardium is
subjected to increased wall stress to compensate for the loss
of contractile tissue . This process leads to lengthening and
hypertrophy of the noninfarcted myocytes that, with time,
may progress to dilation and failure of the left ventricle (1) .
Transient myocardial ischemia may also lead to an increase
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1.80 ± 0.82 and 2.73 ± 0.89 (p < 0.01). In normal control
subjects, basal myocardial blood glow was 0 .92 0.13 and 3 .67 ±
0.94 ml/min per g in the basal state and after dipyridamole (both
p < 0 .05 vs. values in remote regions), and coronary vasodilator
reserve was 4,07 ± 0.98 (p < 0 .01 vs . values in remote regions) .
During pacing there was net lactate release in diseased regions
(®18 ± 27%, p < 0.05 vs . values in remote regions and control
subjects) and extraction in remote regions (38 ± 17%) and in
normal control subjects (26 ± lI%) . Glucose and alanine extrac-
tion were increased in diseased (8 ± 6% and 6 ± 6%) and remote
regions (6 d4 3% and 4 ± 3%), compared with values in normal
control subjects (2 ± 3% and -1 ± 3%, both p < 0 .05 vs.
did and remote regions) .
Conclusions. Coronary vasodilator reserve is reduced and
glucose and alanine metabolism is abnormal in regions subtended
by normal arteries remote from isehemie but noninfarcted myo-
cardium .
U Am Call Caardiol 1993922:650--8)
in left ventricular u ensions associated with regional hy-
perfunction in remote nonischemic areas both in animals
(2-4) and in humans (5,6) . However, it is not known whether
patients with recurrent myocardial ischemia but without
evidence of previous infarction may develop alterations of
cardiac function in the remote regions subtended by angio-
graphically normal coronary arteries .
The aim of this study was to assess whether alterations of
myocardial blood flow and metabolism can be demonstrated
in areas of myocardium subtended by angiographically nor-
mal coronary arteries in patients with chronic stable angina
and disease in other coronary ar .Pries
Methods
Study patients . Twenty-two patients with coronary ar-
tery disease and normal left ventricular function were stud-
ied . No patient had a clinical history or electrocardiographic
(ECG) evidence of previous myocardial infarction, evidence
of valvular or primary myocardial disease or a history of
diabetes or systemic hypertension.
Coronary stenosis severity and regional left ventricular
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PLOW AND METABOLISM PFMOHi FROM IS('HFMIF MYOCARDiLM
Table 1 . Coronary Arteriography in Group I Patients*
function were measured using a computer analysis system in
all patients . In 12 patients (Group 1), regional myocardial
blood flow and coronary vasodilator reserve were assessed
by positron emission tomography . In the other 10 patients
(Group 2), myocardial metaboHsm was easured by simul-
taneous arterial and great cardiac vein catheterization at rest
and during pacing .
Group I . Twelve patients (l) male, mean age 60 years,
range 47 to 76) with significant (>70% diameter stenosis)
single-vessel coronary artery disease were studied . The
remaining coronary arteries in these patients were angio-
graphically normal (Table 1) . All patients had chronic stable
angina pectoris and j0 . I-mil ST segment do iression on the
ECG during exercise . Data from these dents were com-
pared with values in a group of 15 met, (mean age 34 years,
range 21 to 55) who were selected by history and physical
examination as at low risk for coronary artery disease ; all
had a normal ECG at rent and normal responses on exercise
test to a high work load .
Group 2. 'fen additional patients underwent simulta-
neous arterial/great cardiac vein catheterization (Fig
. 1) at
rest and during maximal atrial pacing after routine angiogra-
phy. Five patients (Group 2a, mean age 54 years, range 46 to
65) had significant left anterior descending coronary artery
disease, and five patients (Croup 2b, mean age 52 years,
range 42 to 62) had significant right coronary or left circum-
flex coronary artery disease, or both . All patients in Group
2b had an angiographically normal left anterior descending
artery (Table 2) . Because the great cardiac vein drains blood
from the distribution territory of the left anterior descending
artery, measurements in patients with significant disease of
this artery reflect metabolism in a potentially ischemic
territory (Fig . 2, A and B) . In contrast, in patients with
significant right coronary/left `ircumflex artery disease and a
normal left anterior descending artery ., great cardiac vein
65 1
"Group I = patients with single-ve .
sel disease studied with positron emission tomography . tCohateral vessels are graded according to the method of Rentrop
el al
. t7)
. ANA _: atgiographicalfy normal artery : F = female
: LAD = left anterior descending coronary artery : LCx left circumflex coronary artery : M _- male
:
OM, = first obtuse marginal branch of the left circumflex artery ; PET = positron emission tomography : Pt = patient : RCA = right coronary artery .
measurements reflect metabolism in myocardium remote
from the ischemic zone (Fig . 2, A, C and D) . Metabolic data
from these patients were compared with those from a group
of six control subjects (mean age 47 years, range 39 to 57)
undergoing cardiac catheterization because of a history of
chest pain but with a normal treadmill exercise test result .
These subjects have been reported previously (8) .
Study protocols and data analysis . Quantitative coronartiy
arteriography and left ventriculography . Selective right and
left coronary arteriography in multiple views was performed
with the Judkins technique . Coronary arteriograms were
analyzed by an automated edge contour detection computer
Figure 1 . Coronary venous angiogram (lateral view) obtained after
selective injection of contrast medium into the left anterior descend-
ing coronary artery illustrates the course of the great
cardiac vein .
This vein arises in the anterior myocardial wall and runs posteriorly
and cranially in the interventricular groove and then in
the atrioven-
tricular groove before draining into the coronary sinus, which in turn
drains into the right atrium .
Pt
No.
Age (yr)/
Gender
Extent of Coronary Artery Disease t`i% diameter stenosis and sites
Collateral Grade
PE.,
Remote
Region
LAD RCA
1 47,F 80%=c Proximal ANA ANA 1)
Inferior
2 521[
Occlusion ANA ANA
2 from LCx Inferior
3 56/F 77% proximal ANA ANA 0 Inferior
4 61/11 Occlusion
ANA ANA
3 from RCA Inferior
5 61/M 85% proximal ANA ANA I from RCA
Inferior
6 64111 Occlusion ANA ANA I from LCx, Inferior
7 65/M Occlusion
ANA ANA
2 from LAD
2 from RCA Inferior
8 49/M ANA
88%% proximal ANA, nondominant 3 from RCA
Anterior
9
54/M ANA ANA Occlusion 3 from LCx and LAD Anterior
W (i3/M ANA
73% proximal OM, ANA, nondominant 0
Anterior
f I
70/111 ANA ANA )III proximal I from LCx Anterior
12
76IM ANA ANA 82%%
proximal
0 Anterior
analysis system (Cardiovascular Angiographic Analysis Sys-
tem, Pie Medical Equipment 1W) . The lumen diameter of the
coronary stenosis in the projection showing maximal sever
ity with the adjacent reference segments was measured at
end-diastole. Stenosis severity was expressed as percent
reduction of the internal lumen diameter relative to the
estimated diameter interpolated from the diameters at the
proximal and distal boundaries of the stenosis . Collateral
vessels were graded by two of us (N .G.U . and P.G.C .)
independently, Where 0 = none, I = filling of side branches
*Group 2 - patients with disease of the left anterior descending coronary artery (Group 2a) or of the right coronary or tell circumflex coronary artery or both
(Group 2b) studied with invasive measuremcnts of myocardial metabolism . tcollatecal vessels graded according to the method of Rentrop et al. (7) . GCV = great
cardiac vein -, LADD, - first diagonal bran h of the left anterior descending artery
; RUB = right heart border; other
abbreviations
as in Table 1 .
without visualization of the epicardial segment, 2 = partial
filling of the epicardial segment by means of collateral
vessels, and 3 a= complete filling of the epicardial segment
(7) .
Global and regional left ventricular function were mea-
sured from the 30' right anterior oblique left ventricular
eineangiogram with an automated hard-wired endocardial
contour detector linked to a microcomputer (9,10) . Left
ventricular angiograms were obtained under basal conditions
in all Group 1 and 2 patients. Repeat left ventricular angio-
Pgure 2. A. Anteroposterior view
of the heart (Group 2 patient) dem-
onstrating a temporary pacing wire
in the right atrium, the thermodilu-
tion catheter with its tip well ad-
vanced into the great cardiac vein
and a pigtail catheter in the left ven-
tricular chamber. B, Right anterior
oblique view of the left coronary
system with a severe proximal ste-
nosis in the left anterior descending
artery (Group 2a patient) . C, Right
anterior oblique view of an angio-
graphically normal left anterior de-
scending artery (Group 2b patients)
D, Left ant :.rior oblique view of the
right coronary artery with a proxi-
mal stenosis at the right upper heart
border (Group 2b patient) . See
Methods section for definition of pa-
tient groups .
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TAle 2. Coronary Arteriography in Group 2 Patients*
Pt No.
Age (yr )/
Gender
Extent of Coronary Artery Disease
(% diameter stenosis and site)
Collateral Gradet
Region of GCV
Sampling
-
LAD LCx
RCA
Group2a
t 461M 73% proximal at bifurcation
with LADD,
ANA Mid-RUB occlusion 3 from RCA to RCA
3 from LCx to RCA
Ischenlic
2 48NE >95% proximal. 74% LADD, ON" occlusion 68% distal 2 from RCA ' ~chcmic
3 ON
>95% proximal ANA
ANA 3 from RCA [schemic
4
631M >95% proximal ANA
ANA 2 trots; LCx Ischemic
5
Group 2b
651M 71% proximal, 95% LADD, >95% OM, ANA
I to OM, from RCA
Ischemic
6 421M ANA
ANA Proximal occlusion 3 from LCx Remote
7 491M ANA >95% OM,
Mid-RUB occlusion I from LAD
Remote
531M ANA
47% midvessel stenosis Mid-RUB occlusion 3 from LAD and LCx Remote
9 551M
ANA 43% midvessel stenosis 84"/p proximal 0 Remote
to 62/M ANA ANA Distal orchown
1 from LAD and LCx
Remote
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grams were obtained at maximal pacing in Group 2 patients
and the control subjects Nn one patient of Group 2b, it was not
possible to repeat left ventriculography a[ maximal pacing for
technical reasons). End-systolic and enddiasiolic contours
were drawn to exclude the inferior papillary muscle . Regional
contribution was described in five territories : anterobasal,
anterolateral, apical, inferior and posterobasal (10) . In pa-eats
with anterior/anterolateral ischemia, the posterobasal and infe-
rior regions were defined as remote from the ischemic region,
and in those wii h inferior ischemia the anterobasal and antero-
lalcr,Y, regions were considered remote .
Positron emission tomography . Patients had received no
antianginal medication (except for sublingual nitrates) for at
least 72 h and no sublingual nitrate for >_-2 h before study .
All positron emission tomographic scans were performed
with an ECAT 931-08/12 camera (Computer Technology
Imaging) . Regional myocardial blood flow (pal/rain per g) was
measured on transaxial images in Group I subjects using
oxygen-15-labeled water
(H2"0) as a flow tracer using the
previously validated carbon-15-oxygen inhalation technique
(11) . Measurements were made at rest and 2 min after
intravenous administration of dipyridamole (0 .56 mg/kg for
4 min) .
In patients with left anterior descending artery disease,
the anterior region was designated as the stenosis-related
region and the inferior region as remote . In patients with
right coronary artery/left circumflex artery disease, the inferior
region was designated as the stenosis-related region and the
anterior region as remote . Coronary vasodilator reserve was
defined as the ratio of postdipyridamole myocardial blood flow
to basal myocardial blood flow . Data from patients of Group I
were compared with the average myocardial blood flow in the
control group. Because basal myocardial blood flow is closely
related to the rate-pressure product, an index of myocardial
oxygen consumption, basal myocardial blood flow data were
also corrected for the respective rate-pressure products by the
following equation: Rate-pressure product-corrected basal
myocardial blood flow = Basal myocardial blood flow x
10,000/Rate-pressure product .
Invasive measurement of myocardial substrate metabo-
lism. Patients had received no antianginal medication (ex-
cept for sublingual nitrates) for K2 h and were studied after
an overnight fast of a-13 h . No dextrose solution was
administered during the study . At least 30 min was allowed
between coronary arteriography and the beginning of the
study to minimize any possible interference of the contrast
medium with myocardial metabolism (12) . An 8F multither-
mistor thermodilution pacing catheter was introduced
through either the right femoral vein or the left antecubital
vein and advanced through the coronary sinus into the great
cardiac vein for sampling and measurement of flow in the
distribution territory of the left anterior descending artery
(8,13,14).
Patients performed up to four pacing steps of 4-min
duration each, with heart rate increments of 15 beats/min for
the first three steps and up to maximal achievable heart rate
UREN ET AL
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(exacerbation of symptoms or occurrence of atrioventricular
conduction disturbances, or both) on the last step (no
atropine was used)
. During maximal pacing, at least 2 min
was allowed before the arterial and great cardiac vein blood
samples were obtained and pressures and great cardiac vein
flow weasured. Paired arterial and great cardiac vein blood
samples were drawn under basal conditions and at maximal
pacing for the assay of glucose, free fatty acids, lactate,
pyruvate, alanine and blood gases, as previously reported
(8? . Myocardial oxygen consumption, carbon dioxide pro-
duction, the respiratory quotient, the fractional extraction of
substrates, net rates of carbohydrate and lipid oxidation,
total carbohydrate uptake and myocardial energy expendi-
ture were calculated, as previously described (8,15) .
The positron emission tomographic scanning protocol
was approved by the Research Ethics Committee of Ham-
mersmith Hospital, and the protocol for coronary sinus
catheterization was approved by the Ethics Committee of
the Consiglio Nazionale delle Richerche Institute of Clinical
Physiology . All patients gave informed written consent .
Statistical analysis. All data are expressed as mean value
SD. The Student t test was used to compare any pair of
mean group values . Simultaneous comparison of more than
two mean values was performed using one-way analysis of
variance for repeated measures, and the Fisher least signif-
icant difference method was subsequently applied to localize
the source of the difference (16) . A p value < 0.05 was
considered statistically significant .
ASKS
Results from the positron emission tomographic and
catheter studies are presented separately for ischemic and
remote myocardium, as defined in the Methods section .
Ischemic regions . Regional myocardial blood flow by
positron emission tomography . Global left ventricular func-
tion under basal conditions was normal in all patients in
Group 1 (Table 3) . Heart rate and rate-pressure product in
the basal state and after dipyridamole were not significantly
different in patients and control subjects . Systolic blood
pressure in the basal state and at peak dipyridamole was
higher in patients than in control subjects (132 ± 19 to 137 ±
18 mm Hg, and 115 ± 11 to 115 ± 11 mm Hg (p < 0.05 and
p < 0.01 vs. patients), respectively .
In the ischemic region, basal myocardial blood flaw was
0.96 ± 0 .20 mUmin per g and increased to 1 .73 ± 0 .91 ml/min
per g after dipyridamole treatment (Fig . 3), giving a coronary
vasodilator reserve of 1 .80 ± 0 .82 (Fig . 4). Correcting for
rate-pressure product at rest, basal myocardial blood flow in
the ischemic region was 1 .14 ± 0.23 ml/min per g .
Myocardial metabolism . There was a reduction in left
ventricular ejection fraction from basal state to maximal
pacing from 81 .8 ± 10 .0% to 61 .9 ± 6.9% (p < 0
.01) in Group
2a patients and from 72 .4 ± 7.6% to 57.2 ± 5.5% (p < 0 .05)
in Group 2b patients (Table 4), but the value was unchanged
by pacing in the control group (from 71 .0 ± 7
.1% to 66.0 ±
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Table 3
. Global and Regional Left Ventriculography in Group I Patients
The normal ranges or regional contribution to [ell ventricular function by the CREF (contribution to regional ejection fraction) method are given in
parentheses, LV - left ventricular ; other abbreviations as in Table 1 .
4.9%, p = NS). In Group 2a, rest hemodynamic variables
were comparable to those in the control group, except for a
higher systolic blood pressure (Table 5) . At rest, myocardial
substrate utilization in patients was similar to that hi the
control group (Table 6) . All patients in Group 2a, but none in
the control group, developed chest pain, ST segment depres-
sion (>O. I mV in patients) and wall motion abnormalities on
left ventriculography at maximal pacing (Table 4) at a heart
rate lower than the maximal rate of the control group (126 t
22 vs. 159 ± 23 beats/min, respectively, p < 0 .05) (Table 5) .
The percent increment in L4teat cardiac vein flow during atrial
pacing was less in Group 2a than in the control group, but
Figure 3. The myocardial blood flow in the basal state and after
intravenous administration of dipyridamole (Thp) in the iichernic
region and the remote region of patients with single-vessel coronary
artery disease (Group I) and in normal control subjects .
p<Q01 P4,03
I
Basal Dip
Ischernic Remote
region
region
Patients
Basal Dip
Basal Dip
Controls
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not significantly different (76 ± 64% vs . 133 ± 66
17,o, p = NS) .
The metabolic data during maximal pacing are summarized
in Table 6. Group 2a patients developed metabolic changes
characteristic of myocardial ischemia, that is, increased
glucose extraction with net lactate release . The respiratory
quotient at maximal pacing in the ischemic territory was not
different from the respective basal value (0 .72 ± 0.03 vs .
0.73 ~0. 18), whereas in the control group, respiratory
quotient increased during pacing (0 .72 ± 0.10 vs. 0.84 ±
0.15, p < 0 .05 vs. the basal state), indicating increased
oxidation of carbohydrate fuel .
Remote regions . Regional myocardial blood flow by
positron emission tomography . Basal myocardial blood
flow in the remote region, 1 .06 ± 0.19 mi/min per g, was
Figure 4 . Coronary vasodilator reserve (defined as the ratio of
postdipyi idamole myocardial blood flow to basal myocardial blood
flow) in the ischemic region and remote region of patients with
single-vessel coronary art ;pry disease (Group 1) and in normal
control subjects .
0
r
-l!T
.n1
-
T
Khomit Remote
region region
Patients
Controls
Regional Wall
Motion
(% of contribution)
Pt
No .
Stenosis-Related
Artery
LV Ejection
Fraction (%)
Anterobasal
(14 .4 to 25 .4)
Anterolateral
(10 .1 to 17 .3)
Apical
(2.5 to 6 .3)
Inferior
(10 .6 to 18 .2)
Posterobasal
(15 .7 to 25 .4)
I
LAD
74 .6 17.3 15 .6 4 .1 16 .2 21 .4
2 LAD
81 .5 21 .3
18 .1 4.8 17.8 19.4
3 LAD 82 .8
21 .9 18 .4 3 .8 18 .0 20 .7
4 LAD
.4 25.4 16 .0
4 .8
18.3 23 .9
5 LAD 84 .3 21
.7 18 .2 4 .8 17 .9 21 .7
6 LAD 81 .6
21 .9 19 .1 6 .7 15 .6 18 .3
7 LAD 82 .2 21 .6
17 .6 4 .8 17 .3 20.9
8 LCx 64 .9 18.1
12 .9 4.2 14 .2 15 .5
9 RCA
74 .4 18.6 16,2 5 .2 17.3 16.7
to LCx 80.5 15 .7 18 .2
6 .3
22.8 Its
I I RCA
711 13 .5 17 .3 7 .7 18.4 16.1
12
RCA 79 .1 27.0 16 .2 2 .5 15 .6 17 .8
Mean 1 SD 79 .0 0.3±3
17.04 1 .7 5
.0t 1A
17
. 5 . 2
.1 19.2±2 .8
TAW 4 . Global and Regional Left Ventriculography in Group 2 Patients in the Basal State and at Maximal Pacing
'p < 0 .05 versus control group
. Values are expressed as mean value ± SD
. LV = left ventricular .
15
Basal
State N4cximal Pacing
Regional Wall Motion (7 of contribution)
Regional Wall Motion
14"s
of eontributs;ro}
Pt No.
Stenosis-Related
Artery
1.11 Ejection
Fraction ('5) Apical Inferior
-
Posterobasal
LV Ejec- ion
Fraction (1) &Omni Aminiteral Apical Inferior
Posterobabal
Anterobasal
	
Amerolateral
Group 2a
I L 'D 883 233 17 .6 0 17 .8 23 .1 54 .2 1 E .4 SA 0 .5 11 .6
M!J
2 LAL 86 .6 23A 173 3A 19 .3 23 .2 69A 19 .2 UA 13 17 .1
72
3 LAD 69.7 15.4 12.8 4
.2
15 .8 21 .5 55 .4 4 9 2 .5 14 .6 17 .9
4 LAD 91 .9 243 16 .7 7 .2 17 .9 27 .9 67s 17 .9
5 .1
1
.8 13 .3 27 .9
5 LAD
72.4
18.6
13
.2 4 .2
17 .4 19 .1 62 .8 9.4 1 .6 19 .4 19 .5
Men ± SD
Group 2b
81 .8±10 .1
MS ± 16 15 .5±2 .5
18±1
.1 17 .6±1 .3 BA ± 11 wS=&w 16 .4±2^` 8o=3.18 1.9±I .1° 15 .2±3 .1 ON = V4 .7
6
RCA 69.1 20.8 13.7 2 .4 14 .4
17
.9
62' l G .7 14 .9 5 .6 14 .9 7.4
7 RCATCx 63.1 18.4 15
A
2 .9 13 .2 13 .6 60
A
19 .3
16 .0
3.9 7,7
14 .9
8 RCA 74.4 21 .0 14.0 4.8
14
.4
20
.2
55A 21A 14f
4
.0 5 .8 93
9 RCA 83.8 18.7 20.1 51 18o
20.5
-
10 RCA 71 .5 20.1 13.4
3,1
13.5
20Q8
50.0 M7
I4
.7 3 .3 8 .0
7 .2
Meant SD 72 .4±7 .6 19.8±1 .1
15.2±6 .5
3.9±13 149±2 .2 18 .6±2 .9
57
.2'_6.3'
19
.4±22
151_0.7 2±1 .1 9.1±4 .5° 9 5 ± 30
Total ± SD 79
.0 ± 6
.9
59 .8 ± K5
*p < 0.05 versus
Table 5. Hemodynamic
basal s tate . t p
Variables
< 0 .01 versus
in Group
basal state . Abbreviations
2 Patients
as in Tables 1 and 3 .
Basal State Maximal
Pacing
Systolic Diastolic LV End- Systolic Diastolic
LV End-
Blood Blood Rate-Pressure Diastolic Coronary Blood Blood Rate-Pressure
Diastolic Coronary
Heart Rate Pressure Pressure Product Pressure Resistance Heart Rate Pressure Pressure Product Pressure
Resistance
Subgroups (be-ammin) (mm Hg)
(nun Hg)
(mm Hg/mm) (trum Hg) (U) Subgroups (beamminj (mm Hg)
finia Hg)
(mm
Hg/min) (mm Hg) (U)
Group 2a 70 ± 10 14 t I7' 74 ± 8 10,00 t IX0 6 = 5 1 .84 ± 0 .0 Group 2a I26 ± 2i*
I 49 ± 32 90 ± 16 18,280 ± 744 6 ± 6 124 ± 0 .68
Group 2b 0 ± 6 145 :t 13*
73 ± 10
9,470 ± 1,290 10 m 7 1 .83 ± 0.69
Group 2b
131 ± 19
I42 = 0 84 ± 16 18A30 ± 2,9I0 7 ± 7 IZ r11.57
Control group 76 ± 14 124 ± 16 74 ± 13 9,440 ± 2,190 6 = 3 1.96 ±0.70 Control group I59 ± 23
I34 ± 0
89 = 14
21,130 ± 2,810 8 ± 5 1.03 1 0.49
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Table 6
. Regional Myocardial Metabolism
significantly higher than that in the control group (0 .92 ±
0.13 ml/min per g, p < 0.05) (Fig. 3), After dipyridamole
infusion, myocardial blood flow in the remote regions in-
creased to 2 .89 ± 0.93 ml/min per g, which was greater than
that in the ischemic region (p < 0 .01) (Fig . 3) but lower than
that in the control group (3 .67 ± 0.94 ml/min per g, p < 0 .05) .
Thus, although coronary vasodilator reserve in the remote
regions, 2 .73 ± 0.89, was greater than in the ischemic region
(p < 0.01 vs . ischemic region), it was significantly lower than
that in the control group, 4 .07 ± 0 .98 (p < 0.01 vs. remote
region) (Fig. 4) .
Correcting for rate-pressure product at rest, basal myo-
cardial blood flow was 1 .28 ± 0.30 ml/min per g in the remote
region and 1,21 * 0 .27 ml/min per g in the control subjects
(p NS).
Myocardial metabolism . At baseline, hemodynamic
variables and myocardial substrate utilization were similar to
values in the control group (Tables 4 and 5) . All Group 2b
patients developed chest pain, X0 .1 mV ST segment depres-
sion and regional wall motion abnormalities (Table 4) at
maximal pacing at a rate that was lower than the maximal
heart rate in the control group (131 ± 19 vs . 159
23 beats/min) but not significantly different (Table 5) . Great
cardiac vein flow to the remote region increased by 59
31%, which was significantly lower than the flow increment
in the control group (133 ± 66%, p < 0 .05 vs. Group 2b) . The
metabolic data at maximal pacing are shown in Table 6 . The
extraction of glucose and alanine was significantly higher
than that in the control group
(r
< 0.05), but there were no
differences in lactate extraction, the respiratory quotient and
total carbohydrate oxidation .
Discussion
This study demonstrates that, as expected, the coronary
vasodilator reserve was severely reduced in regions supplied
by stenotic or occluded coronary arteries . Similarly, meta-
JACC Vol. 22, No. 3
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*p < 0
.05,1'p < 0 .01 versus basal state . $p < 0
.05 versus values in control group . Values are expressed as mean value ± SD .
bolic evidence of ischemia was found at pacing stress in
comparable regions in our Group 2a . In addition, a reduced
coronary vasodilator reserve and changes in myocardial
metabolism during stress were found in myocardial regions
subtended by angiographically normal arteries . These results
suggest that, even in the absence of previous infarction,
regions remote from ischemic areas may be altered function-
ally .
The reduction of the coronary vasodilator reserve in the
remote regions was due to the combination of a higher basal
myocardial blood flow and a reduced vasodilator response
after dipyridamole, compared with values in the control
group. The higher basal flow in the remote region was
associated with a higher rate-pressure product at rest and,
after correction for this variable, then ., was no difference in
basal flow when comparing control and remote regions .
Similarly, a reduced coronary vasodilator reserve after ad-
ministration of dipyridamole has been previously reported in
remote regions supplied by angiographically normal arteries
in patients without previous infarction (17) .
Metabolism in the remote myocard' .®pm was characterized
by an increased utilization of carbohydrate fuel at maximal
stress similar to that in the ischemic region (18). This
observation is consistent with previous work demonstrating
an increase in myocardial "F-fluorodeoxyglucose uptake in
regions subtended by nonstenotic arteries in patients with
coronary disease (19). However, although carbohydrates are
used anaerobically in the ischemic region (net lactate re-
lease), they are mainly oxidized in the remote regions, in a
manner similar to that in control subjects .
Potential mechanisms for alterations in remote va ilation
and metabolism. The changes that occur in the remote
nonischemic areas could be due to different mechanisms that
are not necessarily mutually exclusive. The metabolic pat-
tern seen in remote nonischemic areas is consistent with a
previous report of increased glucose utilization in areas
adjacent to ischemic myocardium in isolated pig hearts (20) .
Basal Pacing Maximal Pacing
Ischemic
Region
Remote
Region
Control
Subjects
Ischemic
Region
Remote
Region
Control
Subjects
Oxygen extraction (%) 73.0 t 4.0 71 .6 2:4.1
71 .2 ± 7 .4 69.1 ± 3 .0* 67 .3 ± 6 .4 63 .8 ± 7.0
Oxygen consumption (µmoUmin) 400 ± 225
362 ± 132 301 ± 131 650 ± 369* 535 t 190 593 ± 174f
Respiratory quotient 0 .72 ± 0.03 0.74 ± 0.14 U1 ± 0.10
0 .73 ± 0.18 0.84 ± 0 .17 0.84 ± 0.15*
Free fatty acid extraction (%) 19.1 t 15 .6 31 .3
± 12 .3 30 .3 ± 11 .8 25.3 ± 15.6 20.3 ± 11 .9 22 .0 ± 12 .7
Glucose extraction (%) 7.4 ti 8 .7 -0 .4 ± 7.8 1 .4 ± 3 .9 8.1 ± 5 .6*
6 .4 ± 3 .3# 1 .7 ± 3 .3
Lactate extraction (%) 23.8 ~- 17 .1 31 .0 ± 23 .5
35 .6 ± 11 .9 -17.9 ± 26.9** 38 .2 ± 17.0 25 .7 ± 11 .1
Alanine extraction (%) -1 .0 *_ 13 .5
-1 .9 ± 6.6 -6.1 ± 3 .7 6.2 ± 6 .4# 3 .6 ± 3 .1# -1 .0 ± 3 .2`i
Pyruvate extraction (%) 34.0 t 12 .8 21 .9 ± 28 .0 48 .9 ± 10 .7 -28.7
± 88 .7 20 .8 ± 26.9 32 .8 ± 18 .2*
Carbohydrate uptake (µmoUmin) 21 .0 t 12 .5 4.7 ± 19.8 11
.4 ± 13.6 30.1 ± 26 .6 44 .4 ± 20.7" 25 .8 ± 17 .6
Carbohydrate oxidation (µmollmin) 6 .7 t 10 .2 2.2 ± 23 .4 -1 .1 y 19 .3 19.8 ± 69 .2 37 .4 ± 49.6 45 .0 ± 47 .6*
Lipid uptake (µmoUmin) 8.8 ± 8 .0 11 .3 ± 6.3 10 .0 t° 6 .1 24 .1
± 17.3 9 .5 ± 7 .6 12 .4 ± 25 .1
Lipid oxidation (µmolhasin) 15.7 ± 7,9 15.2 ± 10.8
13 .4 ± 9 .8 23 .2 ± 13 .3 13 .7 ± 14 .4 14 .3 t 15.2
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This could be due to the increased work load on the remote
regions to compensate for the depressed contractile function
in the ischemic zones (20) . Equicaloric replacement of lipid
oxidation by carbohydrate oxidation saves 0 .17 pmollmin of
oxygen consumption per joule of energy produced, giving
greater energy production for the same oxygen consumption
(15) . This hypothesis is consistent with previous experimen-
tal studies that demonstrate that acute coronary occlusion
results in enhanced contractile function in the remote nonisch-
emic zone (2-4) . This might be due to an increased contrac-
tile response in the remote regions compensating for the
temporary dysfunction in the ischemic regions through in-
creased sympathetic nervous system activity that affects
both contractility and carbohydrate metabolism (21) . The
increased sympathetic drive could lead to alpha-adrenergic
coronary vasoconstriction (22) with a reduction in the vaso-
dilator reserve. Also, the impairment in vasodilator reserve
may be a more chronic adaptation to the increased load on
the remote regions witir structural remodeling of the coro-
nary vasculature, as seen in arterial hypertension (23,24) .
Finally, the impairment in vasodilator reserve may also be
an early manifestation of microvascular endothelial dysfunc-
tion in the presence of angiographically undetectable coro-
nary atherosclerosis (25,26) .
Study limitations. Some important considerations limit
the concluFions that can be derived from this preliminary
study. First, the control group studied by positron emission
tomography was significantly younger than the patients, and
it could be argued that coronary vasodilator reserve reduces
with age. However, in a recent positron emission tomogra-
phy study using
H2150 (27) in nine patients with a mean age
of 54 years (range 40 to 73) with normal or minimally
diseased coronary arteries, the coronary vasodilator reserve
to intravenous dipyridamole was 4.4 ± 0.4 and not signifi-
cantly different from a reserve of 3 .8 ± 0 .3 in 16 control
subjects with a mean age of 25 years (range 20 to 35) . Similar
values of coronary vasodilator reserve in response to dipyr-
idamole in control subjects ranging from 18 to 84 years of age
were recently reported by Chan et al . (28) . In our study a
significantly reduced increment in great cardiac vein flow
during pacing was also seen in Group 2b patients when
compared with values in control subjects of similar age . A
second limitation is that the positron emission tomography
scanning and invasive studies were performed in two differ-
ent patient groups, although their clinical characteristics
were very similar. Finally, the number of subjects included
in each study group was small .
Conclusions . Coronary vasodilator reserve is reduced in
remote nonischernic regions of the myocardium in patients
with angina and single-vessel coronary disease . Increased
glucose and alanine extraction also occurs in these remote
regions under pacing stress in the absence of myocardial
ischemia . If confirmed, these alterations in remote regions
may have important implications for the management of
patients with coronary artery disease . In particular, it is
possible that some of the beneficial effects of drugs such as
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beta-adrenergic blocki' - nts and calcium channel anv,. o_
onists may be explained by some effect on myocardial ~
,Iond
flow and metabolism remote from the site of transient
ischemia . Thus, preservation of coronary vasodilator
re-
serve and myocardial metabolism in remote myocardium
may be seen as an additional goal in the treatment of patients
with coronary artery disease .
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